(2026) -
Chronological (1722 items)
(All links open in new tab)
| Oct 19, 2026 |
Bolsonaro vs. Lula: Brazil’s Runoff Could Decide Who Profits From Cannabis in a Country of 200 Million
Flávio Bolsonaro, son of former President Jair Bolsonaro, edged Lula in the first round and has named a cannabis executive as his pick for health minister. With the October 25 runoff days away, Brazil’s patient associations fear a market built for corporations, while investors see an opening in Latin America’s biggest economy. |
|---|---|
| Oct 19, 2026 |
Uganda’s new hemp and medical cannabis cooperative aims to organize farmers, investors
A newly established cooperative in Uganda is seeking to organize farmers and attract investment in industrial hemp and medical cannabis. The Uganda Medical Cannabis and Industrial Hemp Cooperative Society (UMCHICS) is intended to connect licensed producers, investors and government institutions while establishing standards for product quality, traceability and regulatory compliance. At a meeting in Kampala in early October, government officials acknowledged the economic potential of the two crops while warning that licensed operators face penalties for diverting cannabis into illegal markets. |
| Oct 19, 2026 |
What Canada’s Cannabis Shelves Teach About Grading
Every maturing market ends up with a cheap tier and a premium tier. The hard part is proving the premium tier deserves its price. Canada’s legal cannabis market offers an unusual case, because its top grades have no official standard behind them. In Canada, legal since 2018, adults can buy top shelf bud from curated craft ranges that sellers rank above everyday stock. This is information, not an invitation to buy, and the legal age is 19 in most provinces, 18 in Alberta and 21 in Quebec. These sellers ship within Canada only, so readers in Nigeria and across Africa cannot order. Cannabis also remains illegal in Nigeria, and rules differ from country to country. Treat this as a business case for adult readers, not health guidance. |
| Oct 19, 2026 |
Cannabis formulation reduces morphine use by nearly half in clinical trial
A cannabis-based medicine significantly reduced morphine use among hospital patients with severe nerve-related pain, according to the results of a new clinical trial. The study, published in the Journal of Cannabis Research, found that patients given a higher dose of cannabis used 47.6% less morphine over 24 hours than those given a placebo. Despite receiving considerably less morphine, patients in the cannabinoid group did not report significantly higher pain levels, suggesting that cannabis-based medicines could potentially reduce the amount of opioid medication required to manage acute pain. |
| Oct 19, 2026 |
Do THC And CBD Degrade Over Time At Room Temperature?
“To maximize cannabinoid shelf-life and prevent degradation, storage temperatures must match product composition. While CBD-dominant products can tolerate room-temperature storage, THC-rich products require cold chain management, ideally stored in a freezer at -20°C for optimal long-term potency.” the researchers concluded. |
| Oct 19, 2026 |
Morocco's exports of legal cannabis have expanded to 15 countries
Morocco's legal cannabis industry is expanding its international presence, with cannabis resin exports now reaching 15 countries, including France, Switzerland, Portugal, Luxembourg, the Czech Republic, Australia, and South Africa. As the kingdom seeks to establish itself in the global market for cannabis-derived products, its 2026 harvest comes amid stricter regulatory controls as well as a commitment to protecting the identity of its cannabis abroad. |
| Oct 18, 2026 |
Why Is Marijuana Regulated More Strictly Than Alcohol, Even Though It Is Safer To Use? (Op-Ed)
I read the commentary piece by Robert Mellion, executive director of the Massachusetts Package Stores Association, with great bemusement. He argues that oversight of the state’s cannabis sector has been lax and that it should be regulated like alcohol. I think he has it backwards in two fundamental ways. First, alcohol is a much more deadly intoxicant than cannabis. Full stop. It’s worth wondering out loud whether alcohol and cannabis should have the same regulatory regime. Under the existing legal cannabis industry, there have been zero reported deaths from legal cannabis use. The same is not true of alcohol use. Second, cannabis is regulated more comprehensively than virtually any other retail product sold in Massachusetts. |
| Oct 17, 2026 |
First cannabis market study in Missouri finds that legal sales are thriving
The first state-funded study since cannabis was legalized for recreational use in November 2022 found that Missouri’s regulated market has captured 93% of all marijuana transactions, and sales are evenly distributed across the state. The study also found that most consumers purchase flower or “weed” rather than alternatives, and monthly expenditures among all cannabis products averages $161.18 per consumer. Their purchasing decisions are largely driven by price, convenience and strength of the psychoactive substance THC, according to the study results. Overall, the study concluded that the cannabis market is stable and consumers are satisfied with the legal supply available in the state. |
| Oct 17, 2026 |
The first plant-based medical THC spray arrives in the United Kingdom
The Irish pharmaceutical laboratory Dunbar Pharma launches the country's first plant-based THC mouth spray. Made by its British partner IPS Pharma, this new formulation offers an additional administration option to medical specialists, just two months after the launch of THC capsules by the two companies. |
| Oct 17, 2026 |
Moroccan tycoon Lamia Tazi's Sothema wins approval for three cannabis epilepsy drugs
Moroccan pharmaceutical tycoon Lamia Tazi's Sothema, the Casablanca-listed drugmaker controlled by the Tazi and Berrada families, has won marketing authorisations for three cannabis-based medicines to treat epilepsy, its first approvals in the medical cannabis business it has been building for the past several years. The drugs were developed with the Fondation Mohammed VI des Sciences et de la Santé, a Moroccan health and research foundation. None of them is on sale in Morocco yet. Sothema has not disclosed their brand names, formulations, prices or launch dates, or whether the national health insurance scheme will reimburse them. |
| Oct 17, 2026 |
OPINION: Canada’s legal cannabis system has an access problem hiding in plain sight
Eight years after cannabis legalization, Canadians seeking CBD for health-related reasons are still caught between two systems that weren’t built for them. In the recreational market, non-intoxicating products and the people looking for them have been squeezed to the margins of a retail system that rewards high THC and fast sales. Shelf space goes to what moves: an August 2026 review of Ontario’s cannabis catalogue found that just 1.2% of listings were THC-free. OCS data also shows that roughly 80% of new listings are phased out within a year. |
| Oct 17, 2026 |
Medical Cannabis in Germany: THC Prices Vary by a Factor of 12
The price of medical cannabis in Germany varies considerably depending on the formulation: one milligram of THC can cost between €0.12 and €1.40. A new comparative study conducted by the Working Group on Medical Cannabis (Working Group on Cannabis as Medicine – ACM) highlights substantial differences between approved drugs, cannabis extracts, and compounding preparations. |
| Oct 16, 2026 |
Eight Years of Legalization: Canada’s Abandoned Cannabis Policy and Unfinished Industry
The federal government has abandoned cannabis. Not only the industry, but the policy itself. In the lead-up to legalization on October 17, 2018, there was enormous political will and momentum to approach legalization through a public-health lens. But almost immediately after the law took effect, that momentum quickly began to wither. |
| Oct 16, 2026 |
Why Cannabis Stocks Are Looking Dirt Cheap
What does cannabis have to do with disruptive technology investing? Many people ask that question when they see we cover cannabis alongside more than 50 disruptive technology themes. Cannabis is neither a technology nor disruptive, though some might argue it disrupts those who consume too much of it. The backstory behind why we cover cannabis is worth telling because it surrounded the biggest hype cycle we’ve ever seen. |
| Oct 16, 2026 |
The Status of Federal Cannabis Rescheduling
On December 18, 2025 President Trump signed an executive order directing federal agencies to begin expediting the process of rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act.[1] This decision follows years of federal review and empty promises from multiple administrations as medical and retail sales of marijuana have expanded to 40 states and the District of Columbia. Updates since Trump’s announcement have been sparse. |
| Oct 16, 2026 |
Most Pre-Rolls Suck. Josh Kesselman Thinks He Found the Fix, and He Wants the Industry to Copy Him.
Three people who judge cannabis for a living were asked separately what’s wrong with the pre-roll aisle. None knew what the others had said. They landed in almost exactly the same place. Then one of them built a fix and published it so his competitors could steal it. |
| Oct 16, 2026 |
Kentucky Now Has Medical Marijuana Dispensaries Open In Every Region Of The State, Governor Announces
The governor of Kentucky announced on Friday that medical marijuana dispensaries are now open across all 11 licensing regions of the state following the opening of Sunnyside Dispensary in Floyd County this week. “Kentuckians suffering from PTSD, cancer, terminal illnesses, sickle cell anemia and more deserve a safe, non-addictive option for relief, and medical cannabis provides that,” Gov. Andy Beshear (D) said. |
| Oct 16, 2026 |
Morocco revokes 1,490 cannabis licenses amid 2026 harvest and European market push
Morocco's National Agency for the Regulation of Cannabis-Related Activities has revoked 1,490 licenses tied to the country's legal cannabis sector for noncompliance with applicable procedures and regulations, as the 2026 harvest moves forward across the country's three regulated provinces. Of the total licenses withdrawn, nearly 1,300 belonged to cannabis growers and 190 to other operators across the supply chain. The 190 non-grower licenses cover seed imports (60), processing and manufacturing (45), marketing (35), exports (31), seed exports (12) and transportation (7). |
| Oct 15, 2026 |
Cannabis and Health: How Cannabinoids Affect the Human Body
Introduction Researchers are increasingly exploring cannabinoids as bioactive dietary compounds with potential applications in nutrition and health. As research into hemp-derived ingredients expands, scientists are investigating how non-intoxicating cannabinoids interact with the endocannabinoid system (ECS) and other signaling pathways to influence metabolism, inflammation, and disease.2,3 |
| Oct 15, 2026 |
France already has 3,000 cannabis retail outlets. None of them are legal.
France has thousands of drug dealing spots, five million annual cannabis users, and a market worth several billion euros. Yet the sale of cannabis to adults remains illegal. This paradox is reflected in the official figures. According to the Mapping of the Drug Trade in France in 2024 According to government data, there were approximately 3,000 points of sale across the country. This figure includes all types of narcotics, not just cannabis, but it gives an idea of the scale of the distribution networks. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87